here
Access campaign
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB...
July 17, 2024 | India
Access campaign
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in...
July 8, 2024 | South Africa
News & StoriesPress release
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price...
June 18, 2024 |
News & StoriesPress release
India: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration
June 11, 2024 | India
News & StoriesPress release
MSF responds to the outcomes of PPR negotiations at WHA77
June 5, 2024 |
News & StoriesPress release
Gavi’s next strategy must make sure to reach the 10 million children in fragile and...
June 4, 2024 |
Press release
New MSF report shows unacceptable global double standard in diabetes care, even though better treatments...
May 8, 2024 |
Access campaignPress release
MSF reveals cost of its landmark TB clinical trial: €34 million
April 26, 2024 |
Access campaignPress release
As Gavi plans next five-year strategy, it must do more to get vaccines to people...
April 16, 2024 |
Press release
Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests
March 22, 2024 |